Latest Local Technology Business News
- UMass doles out $200K in research grants
- Northeastern professor lands NIH grants for nanotech drug delivery
- FORMA, LLS partner on lymphoma drug development
- Pegasystems pays up to $162M to buy Chordiant
- Pescatello named president of New England Biotech Association
- Boston Scientific stock drops on heart device recall
- Raytheon's Sanchez joins Mass. STEM Advisory Council
- Connecticut backs diagnostics firm HistoRx
- Rapid7 finds $2M in VC funding
- Conn. digital media startup pulls in $550,000 financing
- Rhythm launches to $21M Series A beat
- SS&C reduces IPO pricing to up to $161M
- Satuit buys Lync.NET assets
- GTC Biotherapeutics to be delisted from Nasdaq
- MIT Clean Energy Prize semifinalists named
- Fluidnet rounds out $17M backing for IV fluid pumps
- MHT Exclusive: Kleiner Perkins’ Ray Lane talks clean tech’s future in Boston
- Aveo Pharmaceuticals prices IPO at $81M
- Techstars Boston adds $450K, outlines incubator progress
- Sensata welcomes first-day trading with gain
- GE Aircraft Engines take in $326M deal
- Genetix drug success prompts $35M funding, exec shakeup, hiring plans
- CEO Ken Bero brings team concept Datawatch
- Blue Fang Games counting on Facebook gamers
- Anterion seeks funds amid new drug, market options
- Lander, other Genome Project researchers win U.S.'s biggest medicine prize
- FDA OKs Boston Scientific heart stent
- NMT Medical completes scientific advisory board appointments
- Agios appoints Kaelin to scientific advisory board
- Collaboration revenue gives Synta $79.1M profit
- A123 Systems to make batteries for Navistar electric trucks
- Web startup RunMyErrand to move execs west
- UMass notches record research spending year
- Raytheon slides Yuse into Space and Airborne Systems president role
- CI adds $500K to mobile travel guide app firm
- Pro-Pharmaceuticals lands another $335K in $6M financing
- Panel calls out reluctant Boston-area angels
- Battery Ventures closes $750M ninth fund
- Etex bone substitute gets FDA nod
- Ischemix moves prevention drug to Phase 2a trials
- FDA warns Guidewire of med device process
- Bruker acquires products from Agilent's Varian
- Analogic notes 17 job cuts in recent quarter
- 3Com snags networking deal for Aussie outback schools
- Systematics bought by Maryland firm
- Cerulean brings Elixir vet Roberts in to lead finance, admin
- GT Solar prices $121M secondary stock offering
- Boston rated first among telecommuting cities
- 38 Studios strikes a deal with EA to publish Project Mercury
- Orthopaedic Synergy to buy Praxim
- ImmunoGen cancer drug granted orphan drug status
- Talaris Advisors names Lee as financial and development officer
- Covidien buys Orthofix vascular business
- Startup Watch: Five you should follow
- Collegium Pharmaceutical takes in $1M debt round
- Springpad springs out of Charlestown startup to iPhone
- Ruffolo appointed Crossbeam Systems CEO
- Raytheon exec Jon Jones dies at 55
- PatientsLikeMe, Novartis join on organ transplant online community
- Biogen, Roche halt arthritis drug trial
- Report: Mobile VC dollars plummeted in 2009
- Springfield awarded $500K for energy efficiency programs
Monday, March 15, 2010
Friday, March 12, 2010
Thursday, March 11, 2010
Wednesday, March 10, 2010
Tuesday, March 9, 2010
RSS Feeds
